Literature DB >> 20493775

Roles of small RNAs in tumor formation.

Gianpiero Di Leva1, Carlo M Croce.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that act as post-transcriptional repressors of gene expression in organisms ranging from plants to humans. A widespread role for miRNAs in diverse molecular processes driving the initiation and progression of various tumor types has recently been described. Here, we discuss the etiology of the aberrant expression of miRNAs in human cancers and their role in tumor metastasis, which might define miRNAs as oncogenes or tumor suppressors. Moreover, we highlight the genomic/epigenetic alterations and transcriptional/post-transcriptional mechanisms associated with the misexpression of miRNAs in cancer. A better understanding of miRNA biology might ultimately yield further insight into the molecular mechanisms of tumorigenesis and new therapeutic strategies against cancer. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493775      PMCID: PMC2885513          DOI: 10.1016/j.molmed.2010.04.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  108 in total

1.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

Authors:  Y Murakami; T Yasuda; K Saigo; T Urashima; H Toyoda; T Okanoue; K Shimotohno
Journal:  Oncogene       Date:  2006-04-20       Impact factor: 9.867

2.  MicroRNA deregulation in human thyroid papillary carcinomas.

Authors:  P Pallante; R Visone; M Ferracin; A Ferraro; M T Berlingieri; G Troncone; G Chiappetta; C G Liu; M Santoro; M Negrini; C M Croce; A Fusco
Journal:  Endocr Relat Cancer       Date:  2006-06       Impact factor: 5.678

3.  MicroRNA fingerprints during human megakaryocytopoiesis.

Authors:  Ramiro Garzon; Flavia Pichiorri; Tiziana Palumbo; Rodolfo Iuliano; Amelia Cimmino; Rami Aqeilan; Stefano Volinia; Darshna Bhatt; Hansjuerg Alder; Guido Marcucci; George A Calin; Chang-Gong Liu; Clara D Bloomfield; Michael Andreeff; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

4.  MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.

Authors:  Gianpiero Di Leva; Pierluigi Gasparini; Claudia Piovan; Apollinaire Ngankeu; Michela Garofalo; Cristian Taccioli; Marilena V Iorio; Meng Li; Stefano Volinia; Hansjuerg Alder; Tatsuya Nakamura; Gerard Nuovo; Yunlong Liu; Kenneth P Nephew; Carlo M Croce
Journal:  J Natl Cancer Inst       Date:  2010-04-13       Impact factor: 13.506

5.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Authors:  Stefan Costinean; Nicola Zanesi; Yuri Pekarsky; Esmerina Tili; Stefano Volinia; Nyla Heerema; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

6.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.

Authors:  Yoshimasa Saito; Gangning Liang; Gerda Egger; Jeffrey M Friedman; Jody C Chuang; Gerhard A Coetzee; Peter A Jones
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

Review 7.  E2F1-induced apoptosis: turning killers into therapeutics.

Authors:  Jens Stanelle; Brigitte M Pützer
Journal:  Trends Mol Med       Date:  2006-03-10       Impact factor: 11.951

8.  Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.

Authors:  María J Bueno; Ignacio Pérez de Castro; Marta Gómez de Cedrón; Javier Santos; George A Calin; Juan C Cigudosa; Carlo M Croce; José Fernández-Piqueras; Marcos Malumbres
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

9.  MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.

Authors:  Flavia Pichiorri; Sung-Suk Suh; Marco Ladetto; Michael Kuehl; Tiziana Palumbo; Daniela Drandi; Cristian Taccioli; Nicola Zanesi; Hansjuerg Alder; John P Hagan; Reinhold Munker; Stefano Volinia; Mario Boccadoro; Ramiro Garzon; Antonio Palumbo; Rami I Aqeilan; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

10.  MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.

Authors:  M Garofalo; C Quintavalle; G Di Leva; C Zanca; G Romano; C Taccioli; C G Liu; C M Croce; G Condorelli
Journal:  Oncogene       Date:  2008-02-04       Impact factor: 9.867

View more
  115 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

2.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

Review 3.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

4.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Secil Ak; Hulusi Malyer; Gulendam Tumen; Ayhan Bilir
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-22       Impact factor: 4.553

Review 5.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

6.  MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.

Authors:  Linli Tian; Minghua Li; Jingchun Ge; Yan Guo; Yanan Sun; Ming Liu; Hui Xiao
Journal:  Tumour Biol       Date:  2014-04-01

7.  High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.

Authors:  Man Chen; Yao Liu; Patrick Varley; Ying Chang; Xing-Xing He; Hai Huang; Daolin Tang; Michael T Lotze; Jusheng Lin; Allan Tsung
Journal:  Cancer Res       Date:  2015-02-26       Impact factor: 12.701

Review 8.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

9.  Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.

Authors:  Zhicheng He; Yang Xia; Bin Liu; Xiaotong Qi; Zhi Li; Jun Wang; Liang Chen; Yijiang Chen
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

10.  MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

Authors:  Meng Xu; Hua Jin; Cheng-Xiong Xu; Wen-Zhi Bi; Yan Wang
Journal:  Med Oncol       Date:  2014-05-07       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.